ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Subcutaneous Injection Immunoglobulin Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-18J1073
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Subcutaneous Injection Immunoglobulin Market Insights Forecast to 2028
BUY CHAPTERS

Global Subcutaneous Injection Immunoglobulin Market Research Report 2025

Code: QYRE-Auto-18J1073
Report
September 2025
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Grifols S A
CSL Limited
Takeda

Subcutaneous Injection Immunoglobulin Market Size

The global market for Subcutaneous Injection Immunoglobulin was valued at US$ 2091 million in the year 2024 and is projected to reach a revised size of US$ 3085 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Subcutaneous Injection Immunoglobulin Market

Subcutaneous Injection Immunoglobulin Market

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Subcutaneous Injection Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Injection Immunoglobulin.
The Subcutaneous Injection Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Injection Immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Injection Immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Subcutaneous Injection Immunoglobulin Market Report

Report Metric Details
Report Name Subcutaneous Injection Immunoglobulin Market
Accounted market size in year US$ 2091 million
Forecasted market size in 2031 US$ 3085 million
CAGR 5.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 10% Purity
  • 20% Purity
Segment by Application
  • Primary Immunodeficiency
  • Secondary Immunodeficiency
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, Grifols, CSL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Subcutaneous Injection Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Subcutaneous Injection Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Subcutaneous Injection Immunoglobulin Market growing?

Ans: The Subcutaneous Injection Immunoglobulin Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Subcutaneous Injection Immunoglobulin Market size in 2031?

Ans: The Subcutaneous Injection Immunoglobulin Market size in 2031 will be US$ 3085 million.

Who are the main players in the Subcutaneous Injection Immunoglobulin Market report?

Ans: The main players in the Subcutaneous Injection Immunoglobulin Market are Takeda, Grifols, CSL

What are the Application segmentation covered in the Subcutaneous Injection Immunoglobulin Market report?

Ans: The Applications covered in the Subcutaneous Injection Immunoglobulin Market report are Primary Immunodeficiency, Secondary Immunodeficiency, Others

What are the Type segmentation covered in the Subcutaneous Injection Immunoglobulin Market report?

Ans: The Types covered in the Subcutaneous Injection Immunoglobulin Market report are 10% Purity, 20% Purity

Recommended Reports

Immunoglobulin & Antibodies

Coagulation & Blood Factors

Injection & Drug Delivery

1 Subcutaneous Injection Immunoglobulin Market Overview
1.1 Product Definition
1.2 Subcutaneous Injection Immunoglobulin by Type
1.2.1 Global Subcutaneous Injection Immunoglobulin Market Value Comparison by Type (2024 VS 2031)
1.2.2 10% Purity
1.2.3 20% Purity
1.3 Subcutaneous Injection Immunoglobulin by Application
1.3.1 Global Subcutaneous Injection Immunoglobulin Market Value by Application (2024 VS 2031)
1.3.2 Primary Immunodeficiency
1.3.3 Secondary Immunodeficiency
1.3.4 Others
1.4 Global Subcutaneous Injection Immunoglobulin Market Size Estimates and Forecasts
1.4.1 Global Subcutaneous Injection Immunoglobulin Revenue 2020-2031
1.4.2 Global Subcutaneous Injection Immunoglobulin Sales 2020-2031
1.4.3 Global Subcutaneous Injection Immunoglobulin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Subcutaneous Injection Immunoglobulin Market Competition by Manufacturers
2.1 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Subcutaneous Injection Immunoglobulin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Subcutaneous Injection Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Product Type & Application
2.7 Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Date of Enter into This Industry
2.8 Global Subcutaneous Injection Immunoglobulin Market Competitive Situation and Trends
2.8.1 Global Subcutaneous Injection Immunoglobulin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Subcutaneous Injection Immunoglobulin Players Market Share by Revenue
2.8.3 Global Subcutaneous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Subcutaneous Injection Immunoglobulin Market Scenario by Region
3.1 Global Subcutaneous Injection Immunoglobulin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Subcutaneous Injection Immunoglobulin Sales by Region: 2020-2031
3.2.1 Global Subcutaneous Injection Immunoglobulin Sales by Region: 2020-2025
3.2.2 Global Subcutaneous Injection Immunoglobulin Sales by Region: 2026-2031
3.3 Global Subcutaneous Injection Immunoglobulin Revenue by Region: 2020-2031
3.3.1 Global Subcutaneous Injection Immunoglobulin Revenue by Region: 2020-2025
3.3.2 Global Subcutaneous Injection Immunoglobulin Revenue by Region: 2026-2031
3.4 North America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Country
3.4.1 North America Subcutaneous Injection Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Subcutaneous Injection Immunoglobulin Sales by Country (2020-2031)
3.4.3 North America Subcutaneous Injection Immunoglobulin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Subcutaneous Injection Immunoglobulin Market Facts & Figures by Country
3.5.1 Europe Subcutaneous Injection Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Subcutaneous Injection Immunoglobulin Sales by Country (2020-2031)
3.5.3 Europe Subcutaneous Injection Immunoglobulin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Subcutaneous Injection Immunoglobulin Market Facts & Figures by Region
3.6.1 Asia Pacific Subcutaneous Injection Immunoglobulin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Region (2020-2031)
3.6.3 Asia Pacific Subcutaneous Injection Immunoglobulin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Country
3.7.1 Latin America Subcutaneous Injection Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Subcutaneous Injection Immunoglobulin Sales by Country (2020-2031)
3.7.3 Latin America Subcutaneous Injection Immunoglobulin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Subcutaneous Injection Immunoglobulin Sales by Type (2020-2031)
4.1.1 Global Subcutaneous Injection Immunoglobulin Sales by Type (2020-2025)
4.1.2 Global Subcutaneous Injection Immunoglobulin Sales by Type (2026-2031)
4.1.3 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2020-2031)
4.2 Global Subcutaneous Injection Immunoglobulin Revenue by Type (2020-2031)
4.2.1 Global Subcutaneous Injection Immunoglobulin Revenue by Type (2020-2025)
4.2.2 Global Subcutaneous Injection Immunoglobulin Revenue by Type (2026-2031)
4.2.3 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2020-2031)
4.3 Global Subcutaneous Injection Immunoglobulin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Subcutaneous Injection Immunoglobulin Sales by Application (2020-2031)
5.1.1 Global Subcutaneous Injection Immunoglobulin Sales by Application (2020-2025)
5.1.2 Global Subcutaneous Injection Immunoglobulin Sales by Application (2026-2031)
5.1.3 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2020-2031)
5.2 Global Subcutaneous Injection Immunoglobulin Revenue by Application (2020-2031)
5.2.1 Global Subcutaneous Injection Immunoglobulin Revenue by Application (2020-2025)
5.2.2 Global Subcutaneous Injection Immunoglobulin Revenue by Application (2026-2031)
5.2.3 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2020-2031)
5.3 Global Subcutaneous Injection Immunoglobulin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Subcutaneous Injection Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Subcutaneous Injection Immunoglobulin Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Subcutaneous Injection Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Subcutaneous Injection Immunoglobulin Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Subcutaneous Injection Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Subcutaneous Injection Immunoglobulin Product Portfolio
6.3.5 CSL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Subcutaneous Injection Immunoglobulin Industry Chain Analysis
7.2 Subcutaneous Injection Immunoglobulin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Subcutaneous Injection Immunoglobulin Production Mode & Process Analysis
7.4 Subcutaneous Injection Immunoglobulin Sales and Marketing
7.4.1 Subcutaneous Injection Immunoglobulin Sales Channels
7.4.2 Subcutaneous Injection Immunoglobulin Distributors
7.5 Subcutaneous Injection Immunoglobulin Customer Analysis
8 Subcutaneous Injection Immunoglobulin Market Dynamics
8.1 Subcutaneous Injection Immunoglobulin Industry Trends
8.2 Subcutaneous Injection Immunoglobulin Market Drivers
8.3 Subcutaneous Injection Immunoglobulin Market Challenges
8.4 Subcutaneous Injection Immunoglobulin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Grifols S A
CSL Limited
Takeda
List of Tables
 Table 1. Global Subcutaneous Injection Immunoglobulin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Subcutaneous Injection Immunoglobulin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Subcutaneous Injection Immunoglobulin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Subcutaneous Injection Immunoglobulin Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Subcutaneous Injection Immunoglobulin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Subcutaneous Injection Immunoglobulin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Subcutaneous Injection Immunoglobulin Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Subcutaneous Injection Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Product Type & Application
 Table 12. Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Subcutaneous Injection Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Injection Immunoglobulin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Subcutaneous Injection Immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Subcutaneous Injection Immunoglobulin Sales by Region (2020-2025) & (K Units)
 Table 18. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2020-2025)
 Table 19. Global Subcutaneous Injection Immunoglobulin Sales by Region (2026-2031) & (K Units)
 Table 20. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2026-2031)
 Table 21. Global Subcutaneous Injection Immunoglobulin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2020-2025)
 Table 23. Global Subcutaneous Injection Immunoglobulin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2026-2031)
 Table 25. North America Subcutaneous Injection Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Subcutaneous Injection Immunoglobulin Sales by Country (2020-2025) & (K Units)
 Table 27. North America Subcutaneous Injection Immunoglobulin Sales by Country (2026-2031) & (K Units)
 Table 28. North America Subcutaneous Injection Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Subcutaneous Injection Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Subcutaneous Injection Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Subcutaneous Injection Immunoglobulin Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Subcutaneous Injection Immunoglobulin Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Subcutaneous Injection Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Subcutaneous Injection Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Subcutaneous Injection Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Subcutaneous Injection Immunoglobulin Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Subcutaneous Injection Immunoglobulin Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Subcutaneous Injection Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Subcutaneous Injection Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Subcutaneous Injection Immunoglobulin Sales (K Units) by Type (2020-2025)
 Table 51. Global Subcutaneous Injection Immunoglobulin Sales (K Units) by Type (2026-2031)
 Table 52. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2020-2025)
 Table 53. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2026-2031)
 Table 54. Global Subcutaneous Injection Immunoglobulin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Subcutaneous Injection Immunoglobulin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2020-2025)
 Table 57. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2026-2031)
 Table 58. Global Subcutaneous Injection Immunoglobulin Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Subcutaneous Injection Immunoglobulin Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Subcutaneous Injection Immunoglobulin Sales (K Units) by Application (2020-2025)
 Table 61. Global Subcutaneous Injection Immunoglobulin Sales (K Units) by Application (2026-2031)
 Table 62. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2020-2025)
 Table 63. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2026-2031)
 Table 64. Global Subcutaneous Injection Immunoglobulin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Subcutaneous Injection Immunoglobulin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2020-2025)
 Table 67. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2026-2031)
 Table 68. Global Subcutaneous Injection Immunoglobulin Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Subcutaneous Injection Immunoglobulin Price (USD/Unit) by Application (2026-2031)
 Table 70. Takeda Company Information
 Table 71. Takeda Description and Business Overview
 Table 72. Takeda Subcutaneous Injection Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Takeda Subcutaneous Injection Immunoglobulin Product
 Table 74. Takeda Recent Developments/Updates
 Table 75. Grifols Company Information
 Table 76. Grifols Description and Business Overview
 Table 77. Grifols Subcutaneous Injection Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Grifols Subcutaneous Injection Immunoglobulin Product
 Table 79. Grifols Recent Developments/Updates
 Table 80. CSL Company Information
 Table 81. CSL Description and Business Overview
 Table 82. CSL Subcutaneous Injection Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. CSL Subcutaneous Injection Immunoglobulin Product
 Table 84. CSL Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Subcutaneous Injection Immunoglobulin Distributors List
 Table 88. Subcutaneous Injection Immunoglobulin Customers List
 Table 89. Subcutaneous Injection Immunoglobulin Market Trends
 Table 90. Subcutaneous Injection Immunoglobulin Market Drivers
 Table 91. Subcutaneous Injection Immunoglobulin Market Challenges
 Table 92. Subcutaneous Injection Immunoglobulin Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Subcutaneous Injection Immunoglobulin
 Figure 2. Global Subcutaneous Injection Immunoglobulin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Subcutaneous Injection Immunoglobulin Market Share by Type: 2024 & 2031
 Figure 4. 10% Purity Product Picture
 Figure 5. 20% Purity Product Picture
 Figure 6. Global Subcutaneous Injection Immunoglobulin Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Subcutaneous Injection Immunoglobulin Market Share by Application: 2024 & 2031
 Figure 8. Primary Immunodeficiency
 Figure 9. Secondary Immunodeficiency
 Figure 10. Others
 Figure 11. Global Subcutaneous Injection Immunoglobulin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Subcutaneous Injection Immunoglobulin Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Subcutaneous Injection Immunoglobulin Sales (2020-2031) & (K Units)
 Figure 14. Global Subcutaneous Injection Immunoglobulin Average Price (USD/Unit) & (2020-2031)
 Figure 15. Subcutaneous Injection Immunoglobulin Report Years Considered
 Figure 16. Subcutaneous Injection Immunoglobulin Sales Share by Manufacturers in 2024
 Figure 17. Global Subcutaneous Injection Immunoglobulin Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Subcutaneous Injection Immunoglobulin Players: Market Share by Revenue in Subcutaneous Injection Immunoglobulin in 2024
 Figure 19. Subcutaneous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Subcutaneous Injection Immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 22. North America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 26. Europe Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2020-2031)
 Figure 34. China Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Subcutaneous Injection Immunoglobulin by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Subcutaneous Injection Immunoglobulin by Type (2020-2031)
 Figure 56. Global Subcutaneous Injection Immunoglobulin Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Subcutaneous Injection Immunoglobulin by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Subcutaneous Injection Immunoglobulin by Application (2020-2031)
 Figure 59. Global Subcutaneous Injection Immunoglobulin Price (USD/Unit) by Application (2020-2031)
 Figure 60. Subcutaneous Injection Immunoglobulin Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Subcutaneous Immunoglobulins Market Research Report 2025
Immune Globulin Subcutaneous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Subcutaneous Immunotherapy Market Research Report 2024
Global Subcutaneous Injection Market Research Report 2024
IVIg Liquid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Immunoglobulin pH4 for Intravenous Injection Market Research Report 2024
Global Intravenous Immunoglobulin IVIg Market Research Report 2025
Global Hyperimmune Globulin Injection Market Research Report 2024
Lyophilized IVIG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Immunoglobulin pH4 for Intravenous Injection COVID 19 Market Research Report 2024
Global Subcutaneous Vaccine Adjuvants Market Research Report 2025
Global Infusion Chairs Market Insights Forecast to 2030
Human Rho D Immune Globulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Subcutaneous Medicine Delivery Devices Market Research Report 2024
Global Hyperimmune Globulin Product Market Research Report 2024
IVIg Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Subcutaneous Allergy Immunotherapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intravenous Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravenous Injection Immunoglobulin Market Research Report 2024
Global Human Hyperimmune Globulins Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions